Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki, Ruben Vazquez-Uribe, Jin Li, et al.
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota, Gianluca Ianiro, Anna M. Ahern, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 635-648
Closed Access | Times Cited: 241
The Oral Microbiome and Cancer
Muhammad Irfan, Renata Zoraida Rizental Delgado, Jorge Frias‐Lopez
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 224
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Yusuke Tomita, Tokunori Ikeda, Shinya Sakata, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 10, pp. 1236-1242
Open Access | Times Cited: 168
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Howell Leung, Xiaoxue Long, Yueqiong Ni, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Open Access | Times Cited: 79
Computational frameworks transform antagonism to synergy in optimizing combination therapies
Jinghong Chen, Anqi Lin, Aimin Jiang, et al.
npj Digital Medicine (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota
Guangqi Gao, Teng Ma, Tao Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
Laura Chambers, Emily Esakov Rhoades, Rashmi Bharti, et al.
Cancer Research (2022) Vol. 82, Iss. 24, pp. 4654-4669
Open Access | Times Cited: 65
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
Vinod K. Gupta, Kevin Y. Cunningham, Benjamin Hur, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer
Zizhuo Wang, Xu Qin, Dianxing Hu, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111890-111890
Open Access | Times Cited: 48
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3423-3423
Open Access | Times Cited: 36
Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Xiaoying Hou, Hongzhi Du, Yufei Deng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
Dávid Dóra, Balázs Ligeti, Tamás Kovács, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l -Serine-Mediated NK Cell Activation
Nian Liu, Lihui Chen, Mingjie Yan, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 25
Deciphering the gut microbiome: The revolution of artificial intelligence in microbiota analysis and intervention
Mohammad Abavisani, Alireza Khoshrou, Sobhan Karbas Foroushan, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100211-100211
Open Access | Times Cited: 13
A review of machine learning methods for cancer characterization from microbiome data
Marco Teixeira, Francisco Silva, Rui M. Ferreira, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Applications of Artificial Intelligence in Microbiome Analysis and Probiotic Interventions—An Overview and Perspective Based on the Current State of the Art
Fabiana D’Urso, Francesco Broccolo
Applied Sciences (2024) Vol. 14, Iss. 19, pp. 8627-8627
Open Access | Times Cited: 9
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Understanding genomics and the immune environment of penile cancer to improve therapy
Ahmet M. Aydin, Jad Chahoud, Jacob J. Adashek, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 10, pp. 555-570
Closed Access | Times Cited: 51
Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
Xiaoying Hou, Pei Zhang, Hongzhi Du, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Bacterial resistance to CRISPR-Cas antimicrobials
Ruben Vazquez-Uribe, Christin Rathmer, Leonie J. Jahn, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer
K. Leigh Greathouse, Madhur Wyatt, Abigail J. Johnson, et al.
Neoplasia (2022) Vol. 29, pp. 100800-100800
Open Access | Times Cited: 32
Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract
Karl Alex Hedin, Vanessa E. Rees, Hongbin Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
Despoina Eugenia Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2101-2101
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top